Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06529250
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
Sponsor:
Organization:
None